Iqvia Holdings Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Iqvia Holdings Inc 's ROA in the third quarter of 2026?
Iqvia Holdings Inc achieved a return on average assets (ROA) of 4.62 % in its third quarter of 2026, which is below Iqvia Holdings Inc 's average return on assets, which stands at 5.05%.

ROA fell compared to the second quarter of 2026, despite the net income growth of 36.72% from the second quarter of 2026.

However, within the Healthcare sector 156 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 1231, from total ROA ranking in the second quarter of 2026 at 1428.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	6.08 %	4.36 %	9.92 %	12.52 %	5.69 %
Y / Y Net Income Change	5.42 %	-3.76 %	10.44 %	17.62 %	16.49 %
Net Income (TTM) in million	1,395	1,377	1,387	1,361	1,284
Return On Assets (TTM)	4.62 %	4.63 %	4.72 %	4.74 %	4.6 %
IQV's Total Ranking	# 1231	# 1428	# 1263	# 1282	# 1218
Total Assets (TTM) in million	30,474	29,881	30,032	30,268	28,727
Seq. Total Assets Change	1.98 %	-0.5 %	-0.78 %	5.36 %	0.33 %
Seq. Net Income Change	36.72 %	-6.91 %	-46.5 %	54.82 %	24.81 %

IQV's 5 Years Annual ROA >> Back to IQV Management Effectiveness >> Compare IQV ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 11
Sector	# 157
Overall	# 1246

Return On Assets Statistics
High	Average	Low
11.45 %	5.05 %	0.33 %
(Dec 31 2014)		(Sep 30 2017)

Financial Statements
Iqvia Holdings Inc 's Assets	$ 30,474 million	IQV's Balance sheet
Iqvia Holdings Inc 's Income	$ 350 million	Quarterly IQV's Income Statement
IQV's Income by Division		See IQV's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	12.52 %	0.82 %	5.3 %	2.62 %	0.51 %
Total Assets in million	30,268	26,899	26,681	25,337	24,689
Y / Y Net Income Change	-0.87 %	1.1 %	24.47 %	12.36 %	215.26 %
Net Income in million	1,361	1,373	1,358	1,091	971
Annual Return On Assets	4.5 %	5.1 %	5.09 %	4.31 %	3.93 %

IQV's 5 Years Annual ROA >> Back to IQV Management Effectiveness >> Compare IQV ROA to its Competitors

Comment on IQV's ROA in the fiscal year ending 2025

In the fiscal year 2025 Iqvia Holdings Inc 's ROA decreased compared to previous year to 4.5 %, due to deterioration of net income -0.87 % to $1,361.00 million, from $1,373.00 million a year ago, as IQV's assets were $30,268.00 million.

More Return On Assets Ratios
IQV's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IQV's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IQV's Competitors
Subscribers only: Roa for Iqvia Holdings Inc 's Suppliers
Subscribers only: Return On Assets for IQV's Customers

You may also want to know
IQV's Roi	IQV's Inventory Turnover Ratio	IQV's Growth Rates	IQV's Dividend Comparisons
	IQV's Profitability Ratios	IQV's Asset Turnover Ratio	IQV's Dividend Growth
IQV's Roe	IQV's Valuation Ratios	IQV's Financial Strength Ratios	IQV's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Bio rad Laboratories Inc	9.88 %
3m Company	9.60 %
Bioventus Inc	9.47 %
Medinotec Inc	8.67 %
Tactile Systems Technology Inc	8.53 %
Penumbra Inc	8.13 %
Johnson and Johnson	8.06 %
Pacific Health Care Organization Inc	7.83 %
Boston Scientific Corporation	7.82 %
Ani Pharmaceuticals Inc	7.77 %
Stryker Corp	7.66 %
Abbvie Inc	7.48 %
Ensign Group Inc	7.00 %
Pediatrix Medical Group Inc	6.99 %
Quest Diagnostics Inc	6.96 %
Davita Inc	6.65 %
Brightspring Health Services Inc	6.60 %
Ge Healthcare Technologies Inc	5.85 %

Date modified: 2026-10-28T09:25:56+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.